Retirement Wealth Solutions
LKFT icon

Retirement Wealth Solutions’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Retirement Wealth Solutions’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$327 Buy
11
+2
+22% +$57 ﹤0.01% 857
2026
Q2 		$270 Sell
9
-3
-25% -$85 ﹤0.01% 765
2026
Q1 		$360 Buy
+12
New +$397 ﹤0.01% 754

Other funds holding LKFT

Gilead Sciences
Gilead Sciences Foster City, California $1.46B AUM 71.23% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
denkapparat Operations
denkapparat Operations Berlin, Germany $379M AUM 28.36% 1-Year Est. Return
Crossmark Global Holdings
Crossmark Global Holdings Houston, Texas $7.69B AUM 31.68% 1-Year Est. Return
Monaco Asset Management
Monaco Asset Management Monaco $818M AUM 32.61% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
MQS Management
MQS Management New York $171M AUM 3.86% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $134B AUM 35.21% 1-Year Est. Return

Retirement Wealth Solutions's LKFT Position: Q3 2026 in Review

Retirement Wealth Solutions increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 22% in Q3 2026, buying an estimated $57 and bringing the position to 11 shares worth $327. The position accounts for ﹤0.01% of the portfolio, ranked #857.

Retirement Wealth Solutions first reported a position in LKFT in Q1 2026 and has held it in 3 quarters since. The position peaked at $360 in Q1 2026. 40 funds tracked by Wall St. Rank hold LKFT as of Q3 2026.

  • Retirement Wealth Solutions held 11 shares of Lakefront Biotherapeutics American Depositary Shares worth $327 as of Q3 2026.
  • Retirement Wealth Solutions bought 2 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2026, an estimated $57.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Retirement Wealth Solutions's portfolio in Q3 2026, its #857 holding.
  • Retirement Wealth Solutions first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2026 and has held it in 3 quarters since.
  • Retirement Wealth Solutions's Lakefront Biotherapeutics American Depositary Shares position peaked at $360 in Q1 2026.
  • 40 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2026.

Based on Retirement Wealth Solutions's 13F filing for Q3 2026, filed 7 Oct 2026.